Status:
NOT_YET_RECRUITING
Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program in Patients With Interstitial Lung Diseases and Its Impact on Quality of Life
Lead Sponsor:
Hospital Civil de Guadalajara
Conditions:
Lung Disease Interstitial Diffuse
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Interstitial lung diseases cause scarring and stiffness of the lungs, leading to impaired breathing and reduced quality of life. The diaphragm, the main respiratory muscle, may become weakened in thes...
Detailed Description
This is a prospective longitudinal before-after study designed to evaluate the impact of a structured pulmonary rehabilitation program on diaphragmatic function and patient-reported outcomes in indivi...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Confirmed diagnosis of interstitial lung disease (ILD) by pulmonology and imaging criteria.
- Clinically stable for at least 4 weeks prior to enrollment (no exacerbations or hospitalizations).
- Able to perform pulmonary rehabilitation and functional tests safely, as determined by medical evaluation.
- Willing and able to provide written informed consent.
Exclusion
- Acute exacerbation of ILD or respiratory infection within the last 4 weeks.
- Severe comorbidities limiting participation (e.g., unstable cardiac disease, uncontrolled hypertension, recent myocardial infarction \< 3 months).
- Advanced neuromuscular disease or musculoskeletal limitation that prevents exercise training.
- Cognitive impairment or psychiatric condition interfering with protocol adherence.
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
September 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07205627
Start Date
September 25 2025
End Date
December 30 2025
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Rehabilitation at the Civil Hospital of Guadalajara
Guadalajara, Jalisco, Mexico, 44280